Teva launches generic hypertension drugs

Generic drug maker announces release of irbesartan, irbesartan/hydrochlorothiazide

JERUSALEM — Teva Pharmaceutical Industries has launched generic versions of two blood pressure drugs made by Sanofi, Teva said Monday.

Teva announced the launch of irbesartan and irbesartan/hydrochlorothiazide tablets, respectively generic versions of Avapro and Avalide. Avapro has annual sales of $464 million, and Avalide has annual sales of $124 million, according to IMS Health. Both drugs are used to treat high blood pressure, also known as hypertension.

Teva was the first company to file for and win approval for generic versions of the drug, entitling it to 180 days of market exclusivity in which to compete directly with Sanofi's products.


Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter.

Login or Register to post a comment.